Christian G Aragonez1,2, Vincent J de Beer3, Darla L Tharp1, Douglas K Bowles1,4,5, M Harold Laughlin1,4,5, Daphne Merkus3, Dirk J Duncker3, Shawn B Bender1,2,4. 1. Biomedical Sciences, University of Missouri, Columbia, Missouri. 2. Research Service, Harry S Truman Memorial Veterans Hospital, Columbia, Missouri. 3. Division of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Cardiovascular Research School COEUR, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. 4. Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri. 5. Medical Pharmacology and Physiology, University of Missouri, Columbia, Missouri.
Abstract
OBJECTIVE: Swine with familial hypercholesterolemia (FH) exhibit attenuated exercise-induced systemic vasodilation that is restored by phosphodiesterase 5 (PDE5) inhibition. Whether the impacts of FH and PDE5 inhibition to impair and restore exercise-induced vasodilation, respectively, results from tissue-specific or generalized effects remains unclear. Thus, we hypothesized that FH induces generalized impairment of skeletal muscle vasodilation that would be alleviated by PDE5 inhibition. METHODS: Systemic vascular responses to exercise were assessed in chronically instrumented normal and FH swine before and after PDE5 inhibition with EMD360527. Skeletal muscle and organ blood flows and conductances were determined via the microsphere technique. RESULTS: As previously reported, vs normal swine, FH swine have pronounced elevation of total cholesterol and impaired exercise-induced vasodilation that is restored by PDE5 inhibition. Blood flows to several, not all, skeletal muscle vascular beds were severely impaired by FH associated with reduced blood flow to many visceral organs. PDE5 inhibition differentially impacted skeletal muscle and organ blood flows in normal and FH swine. CONCLUSIONS: These data indicate that FH induces regional, not generalized, vasomotor dysfunction and that FH and normal swine exhibit unique tissue blood flow responses to PDE5 inhibition thereby adding to accumulating evidence of vascular bed-specific dysfunction in co-morbid conditions.
OBJECTIVE:Swine with familial hypercholesterolemia (FH) exhibit attenuated exercise-induced systemic vasodilation that is restored by phosphodiesterase 5 (PDE5) inhibition. Whether the impacts of FH and PDE5 inhibition to impair and restore exercise-induced vasodilation, respectively, results from tissue-specific or generalized effects remains unclear. Thus, we hypothesized that FH induces generalized impairment of skeletal muscle vasodilation that would be alleviated by PDE5 inhibition. METHODS: Systemic vascular responses to exercise were assessed in chronically instrumented normal and FHswine before and after PDE5 inhibition with EMD360527. Skeletal muscle and organ blood flows and conductances were determined via the microsphere technique. RESULTS: As previously reported, vs normal swine, FHswine have pronounced elevation of total cholesterol and impaired exercise-induced vasodilation that is restored by PDE5 inhibition. Blood flows to several, not all, skeletal muscle vascular beds were severely impaired by FH associated with reduced blood flow to many visceral organs. PDE5 inhibition differentially impacted skeletal muscle and organ blood flows in normal and FHswine. CONCLUSIONS: These data indicate that FH induces regional, not generalized, vasomotor dysfunction and that FH and normal swine exhibit unique tissue blood flow responses to PDE5 inhibition thereby adding to accumulating evidence of vascular bed-specific dysfunction in co-morbid conditions.
Authors: Vincent J de Beer; Daphne Merkus; Shawn B Bender; Darla L Tharp; Douglas K Bowles; Dirk J Duncker; M Harold Laughlin Journal: J Appl Physiol (1985) Date: 2013-10-24
Authors: Sarah D de Ferranti; Angie Mae Rodday; Michael M Mendelson; John B Wong; Laurel K Leslie; R Christopher Sheldrick Journal: Circulation Date: 2016-03-15 Impact factor: 29.690
Authors: Andrew J Maxwell; Josef Niebauer; Patrick S Lin; Philip S Tsao; Daniel Bernstein; John P Cooke Journal: Vasc Med Date: 2009-08 Impact factor: 3.239
Authors: Muhiddin A Ozkor; Salim S Hayek; Ayaz M Rahman; Jonathan R Murrow; Nino Kavtaradze; Ji Lin; Amita Manatunga; Arshed A Quyyumi Journal: Vasc Med Date: 2015-02-03 Impact factor: 4.739